Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
FOXO3
|
ENSG00000118689.15 | FOXO3 |
FOXD2
|
ENSG00000186564.6 | FOXD2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
FOXD2 | hg38_v1_chr1_+_47438036_47438112 | -0.25 | 1.7e-01 | Click! |
FOXO3 | hg38_v1_chr6_+_108656346_108656359 | 0.15 | 4.4e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_+_84164962 | 3.35 |
ENST00000614872.4
ENST00000394839.6 |
PRKACB
|
protein kinase cAMP-activated catalytic subunit beta |
chr11_-_102955705 | 2.68 |
ENST00000615555.4
ENST00000340273.4 ENST00000260302.8 |
MMP13
|
matrix metallopeptidase 13 |
chr6_+_73696145 | 2.67 |
ENST00000287097.6
|
CD109
|
CD109 molecule |
chr14_+_85533167 | 2.53 |
ENST00000682132.1
|
FLRT2
|
fibronectin leucine rich transmembrane protein 2 |
chr8_-_29350666 | 2.52 |
ENST00000240100.7
|
DUSP4
|
dual specificity phosphatase 4 |
chr3_+_172750682 | 2.41 |
ENST00000232458.9
ENST00000540509.5 |
ECT2
|
epithelial cell transforming 2 |
chr1_-_121183911 | 2.23 |
ENST00000355228.8
|
FAM72B
|
family with sequence similarity 72 member B |
chr7_-_27095972 | 2.18 |
ENST00000355633.5
ENST00000643460.2 |
HOXA1
|
homeobox A1 |
chr4_-_110198579 | 2.17 |
ENST00000302274.8
|
ELOVL6
|
ELOVL fatty acid elongase 6 |
chr4_-_110198650 | 2.17 |
ENST00000394607.7
|
ELOVL6
|
ELOVL fatty acid elongase 6 |
chr3_+_172750715 | 2.09 |
ENST00000392692.8
ENST00000417960.5 ENST00000428567.5 ENST00000366090.6 ENST00000426894.5 |
ECT2
|
epithelial cell transforming 2 |
chr8_+_31639755 | 2.04 |
ENST00000520407.5
|
NRG1
|
neuregulin 1 |
chr7_+_134779663 | 1.77 |
ENST00000361901.6
|
CALD1
|
caldesmon 1 |
chr7_+_134779625 | 1.73 |
ENST00000454108.5
ENST00000361675.7 |
CALD1
|
caldesmon 1 |
chr7_+_80638510 | 1.72 |
ENST00000433696.6
ENST00000538969.5 ENST00000544133.5 |
CD36
|
CD36 molecule |
chr1_-_20486197 | 1.72 |
ENST00000375078.4
|
CAMK2N1
|
calcium/calmodulin dependent protein kinase II inhibitor 1 |
chr7_-_41703062 | 1.69 |
ENST00000242208.5
|
INHBA
|
inhibin subunit beta A |
chr10_+_97640686 | 1.64 |
ENST00000370631.3
|
PI4K2A
|
phosphatidylinositol 4-kinase type 2 alpha |
chr19_-_42412347 | 1.63 |
ENST00000601189.1
ENST00000599211.1 |
LIPE
|
lipase E, hormone sensitive type |
chr9_+_72577939 | 1.63 |
ENST00000645773.1
|
TMC1
|
transmembrane channel like 1 |
chr12_+_13196718 | 1.63 |
ENST00000431267.2
ENST00000542474.5 ENST00000544053.5 ENST00000256951.10 |
EMP1
|
epithelial membrane protein 1 |
chr1_+_84164370 | 1.59 |
ENST00000446538.5
ENST00000610703.4 ENST00000370682.7 ENST00000394838.6 ENST00000432111.5 |
PRKACB
|
protein kinase cAMP-activated catalytic subunit beta |
chr11_+_844406 | 1.43 |
ENST00000397404.5
|
TSPAN4
|
tetraspanin 4 |
chr6_+_73695779 | 1.38 |
ENST00000422508.6
ENST00000437994.6 |
CD109
|
CD109 molecule |
chrX_+_38006551 | 1.32 |
ENST00000297875.7
|
SYTL5
|
synaptotagmin like 5 |
chr1_+_152514474 | 1.30 |
ENST00000368790.4
|
CRCT1
|
cysteine rich C-terminal 1 |
chr7_+_80638662 | 1.26 |
ENST00000394788.7
|
CD36
|
CD36 molecule |
chr7_+_107168961 | 1.25 |
ENST00000468410.5
ENST00000478930.5 ENST00000464009.1 ENST00000222574.9 |
HBP1
|
HMG-box transcription factor 1 |
chr4_+_73740541 | 1.25 |
ENST00000401931.1
ENST00000307407.8 |
CXCL8
|
C-X-C motif chemokine ligand 8 |
chr14_+_56117702 | 1.22 |
ENST00000559044.5
|
PELI2
|
pellino E3 ubiquitin protein ligase family member 2 |
chr17_-_40984297 | 1.21 |
ENST00000377755.9
|
KRT40
|
keratin 40 |
chr12_+_53097656 | 1.21 |
ENST00000301464.4
|
IGFBP6
|
insulin like growth factor binding protein 6 |
chr5_-_142686079 | 1.21 |
ENST00000337706.7
|
FGF1
|
fibroblast growth factor 1 |
chr7_+_129368123 | 1.18 |
ENST00000460109.5
ENST00000474594.5 |
AHCYL2
|
adenosylhomocysteinase like 2 |
chr1_-_120100688 | 1.18 |
ENST00000652264.1
|
NOTCH2
|
notch receptor 2 |
chr7_+_107660819 | 1.16 |
ENST00000644269.2
|
SLC26A4
|
solute carrier family 26 member 4 |
chr2_+_113127588 | 1.14 |
ENST00000409930.4
|
IL1RN
|
interleukin 1 receptor antagonist |
chr12_-_122703346 | 1.14 |
ENST00000328880.6
|
HCAR2
|
hydroxycarboxylic acid receptor 2 |
chr11_+_46380932 | 1.12 |
ENST00000441869.5
|
MDK
|
midkine |
chr15_-_34337719 | 1.12 |
ENST00000559484.1
ENST00000558589.5 ENST00000458406.6 |
SLC12A6
|
solute carrier family 12 member 6 |
chr7_+_130266847 | 1.11 |
ENST00000222481.9
|
CPA2
|
carboxypeptidase A2 |
chr12_-_27970047 | 1.10 |
ENST00000395868.7
|
PTHLH
|
parathyroid hormone like hormone |
chr17_+_76376581 | 1.10 |
ENST00000591651.5
ENST00000545180.5 |
SPHK1
|
sphingosine kinase 1 |
chr7_+_77840122 | 1.09 |
ENST00000450574.5
ENST00000248550.7 |
PHTF2
|
putative homeodomain transcription factor 2 |
chr11_+_33039561 | 1.08 |
ENST00000334274.9
|
TCP11L1
|
t-complex 11 like 1 |
chr8_+_11809135 | 1.08 |
ENST00000528643.5
ENST00000525777.5 |
FDFT1
|
farnesyl-diphosphate farnesyltransferase 1 |
chr7_-_100100716 | 1.07 |
ENST00000354230.7
ENST00000425308.5 |
MCM7
|
minichromosome maintenance complex component 7 |
chr11_+_33039996 | 1.04 |
ENST00000432887.5
ENST00000528898.1 ENST00000531632.6 |
TCP11L1
|
t-complex 11 like 1 |
chr4_-_158173004 | 1.03 |
ENST00000585682.6
|
GASK1B
|
golgi associated kinase 1B |
chr11_+_46380746 | 1.03 |
ENST00000405308.6
|
MDK
|
midkine |
chr10_+_80413817 | 1.03 |
ENST00000372187.9
|
PRXL2A
|
peroxiredoxin like 2A |
chr17_+_28335718 | 1.02 |
ENST00000226225.7
|
TNFAIP1
|
TNF alpha induced protein 1 |
chr15_-_34338033 | 1.02 |
ENST00000558667.5
ENST00000561120.5 ENST00000559236.5 ENST00000397702.6 |
SLC12A6
|
solute carrier family 12 member 6 |
chr4_-_138242325 | 1.00 |
ENST00000280612.9
|
SLC7A11
|
solute carrier family 7 member 11 |
chr1_+_171185293 | 0.98 |
ENST00000209929.10
|
FMO2
|
flavin containing dimethylaniline monoxygenase 2 |
chr4_-_140154176 | 0.97 |
ENST00000509479.6
|
MAML3
|
mastermind like transcriptional coactivator 3 |
chr15_+_41256907 | 0.97 |
ENST00000560965.1
|
CHP1
|
calcineurin like EF-hand protein 1 |
chr6_+_12290353 | 0.97 |
ENST00000379375.6
|
EDN1
|
endothelin 1 |
chr10_+_122163590 | 0.95 |
ENST00000368999.5
|
TACC2
|
transforming acidic coiled-coil containing protein 2 |
chr4_-_56681588 | 0.95 |
ENST00000554144.5
ENST00000381260.7 |
HOPX
|
HOP homeobox |
chr6_-_27912396 | 0.93 |
ENST00000303324.4
|
OR2B2
|
olfactory receptor family 2 subfamily B member 2 |
chr4_-_47981535 | 0.92 |
ENST00000402813.9
|
CNGA1
|
cyclic nucleotide gated channel subunit alpha 1 |
chr17_+_28335571 | 0.92 |
ENST00000544907.6
|
TNFAIP1
|
TNF alpha induced protein 1 |
chr12_-_27970273 | 0.91 |
ENST00000542963.1
ENST00000535992.5 |
PTHLH
|
parathyroid hormone like hormone |
chr8_+_119067239 | 0.91 |
ENST00000332843.3
|
COLEC10
|
collectin subfamily member 10 |
chr5_-_147453888 | 0.90 |
ENST00000398514.7
|
DPYSL3
|
dihydropyrimidinase like 3 |
chr20_+_64164474 | 0.90 |
ENST00000622439.4
ENST00000536311.5 |
MYT1
|
myelin transcription factor 1 |
chr19_-_45406327 | 0.90 |
ENST00000593226.5
ENST00000418234.6 |
PPP1R13L
|
protein phosphatase 1 regulatory subunit 13 like |
chr12_-_91180365 | 0.90 |
ENST00000547937.5
|
DCN
|
decorin |
chr9_+_72577369 | 0.90 |
ENST00000651183.1
|
TMC1
|
transmembrane channel like 1 |
chr11_+_117178886 | 0.89 |
ENST00000620360.4
|
SIDT2
|
SID1 transmembrane family member 2 |
chr2_+_113117889 | 0.88 |
ENST00000361779.7
ENST00000259206.9 ENST00000354115.6 |
IL1RN
|
interleukin 1 receptor antagonist |
chr7_+_134866831 | 0.88 |
ENST00000435928.1
|
CALD1
|
caldesmon 1 |
chr20_+_64164566 | 0.88 |
ENST00000650655.1
|
MYT1
|
myelin transcription factor 1 |
chr12_-_52385649 | 0.87 |
ENST00000257951.3
|
KRT84
|
keratin 84 |
chr12_-_27971970 | 0.87 |
ENST00000395872.5
ENST00000201015.8 |
PTHLH
|
parathyroid hormone like hormone |
chr1_+_209704836 | 0.87 |
ENST00000367027.5
|
HSD11B1
|
hydroxysteroid 11-beta dehydrogenase 1 |
chr20_+_64164446 | 0.87 |
ENST00000328439.6
|
MYT1
|
myelin transcription factor 1 |
chr5_-_16742221 | 0.86 |
ENST00000505695.5
|
MYO10
|
myosin X |
chr6_-_42048648 | 0.86 |
ENST00000502771.1
ENST00000508143.5 ENST00000514588.1 ENST00000510503.5 |
CCND3
|
cyclin D3 |
chr11_-_82846128 | 0.85 |
ENST00000679809.1
ENST00000680186.1 ENST00000681592.1 |
PRCP
|
prolylcarboxypeptidase |
chr1_-_161223559 | 0.84 |
ENST00000469730.2
ENST00000463273.5 ENST00000464492.5 ENST00000367990.7 ENST00000470459.6 ENST00000463812.1 ENST00000468465.5 |
APOA2
|
apolipoprotein A2 |
chr10_+_122163672 | 0.84 |
ENST00000369004.7
ENST00000260733.7 |
TACC2
|
transforming acidic coiled-coil containing protein 2 |
chr4_-_102345469 | 0.83 |
ENST00000356736.5
ENST00000682932.1 |
SLC39A8
|
solute carrier family 39 member 8 |
chrX_-_107717054 | 0.83 |
ENST00000503515.1
ENST00000372397.6 |
TSC22D3
|
TSC22 domain family member 3 |
chr1_-_206202419 | 0.83 |
ENST00000607379.1
ENST00000341209.9 |
FAM72A
|
family with sequence similarity 72 member A |
chr4_+_89111521 | 0.83 |
ENST00000603357.3
|
TIGD2
|
tigger transposable element derived 2 |
chr9_+_72628020 | 0.82 |
ENST00000646619.1
|
TMC1
|
transmembrane channel like 1 |
chr2_-_162243375 | 0.82 |
ENST00000188790.9
ENST00000443424.5 |
FAP
|
fibroblast activation protein alpha |
chr10_-_104085847 | 0.82 |
ENST00000648076.2
|
COL17A1
|
collagen type XVII alpha 1 chain |
chr2_-_191847068 | 0.82 |
ENST00000304141.5
|
CAVIN2
|
caveolae associated protein 2 |
chr5_-_73448769 | 0.82 |
ENST00000615637.3
|
FOXD1
|
forkhead box D1 |
chr7_+_134891566 | 0.81 |
ENST00000424922.5
ENST00000495522.1 |
CALD1
|
caldesmon 1 |
chr15_-_34337772 | 0.81 |
ENST00000354181.8
|
SLC12A6
|
solute carrier family 12 member 6 |
chr11_+_117178728 | 0.81 |
ENST00000532960.5
ENST00000324225.9 |
SIDT2
|
SID1 transmembrane family member 2 |
chr17_-_66229380 | 0.80 |
ENST00000205948.11
|
APOH
|
apolipoprotein H |
chr8_+_85463997 | 0.80 |
ENST00000285379.10
|
CA2
|
carbonic anhydrase 2 |
chr11_-_115504389 | 0.79 |
ENST00000545380.5
ENST00000452722.7 ENST00000331581.11 ENST00000537058.5 ENST00000536727.5 ENST00000542447.6 |
CADM1
|
cell adhesion molecule 1 |
chr2_-_189179754 | 0.79 |
ENST00000374866.9
ENST00000618828.1 |
COL5A2
|
collagen type V alpha 2 chain |
chr10_+_122163426 | 0.79 |
ENST00000360561.7
|
TACC2
|
transforming acidic coiled-coil containing protein 2 |
chr11_-_82845734 | 0.79 |
ENST00000681883.1
ENST00000680040.1 ENST00000681432.1 |
PRCP
|
prolylcarboxypeptidase |
chr4_-_151227881 | 0.78 |
ENST00000652233.1
ENST00000514152.5 |
SH3D19
|
SH3 domain containing 19 |
chr11_+_13277639 | 0.78 |
ENST00000527998.5
ENST00000529388.6 ENST00000401424.6 ENST00000403510.8 ENST00000403290.6 ENST00000533520.5 ENST00000389707.8 ENST00000673817.1 |
ARNTL
|
aryl hydrocarbon receptor nuclear translocator like |
chr6_-_32154326 | 0.76 |
ENST00000475826.1
ENST00000485392.5 ENST00000494332.5 ENST00000498575.1 ENST00000428778.5 |
ENSG00000284954.1
ENSG00000285085.1
|
novel transcript novel protein |
chr20_+_35172046 | 0.76 |
ENST00000216968.5
|
PROCR
|
protein C receptor |
chr17_-_59151794 | 0.76 |
ENST00000584089.1
|
SKA2
|
spindle and kinetochore associated complex subunit 2 |
chr22_+_50170720 | 0.75 |
ENST00000159647.9
ENST00000395842.3 |
PANX2
|
pannexin 2 |
chr11_+_844067 | 0.75 |
ENST00000397406.5
ENST00000409543.6 ENST00000525201.5 |
TSPAN4
|
tetraspanin 4 |
chr19_+_41219177 | 0.73 |
ENST00000301178.9
|
AXL
|
AXL receptor tyrosine kinase |
chr20_+_59676661 | 0.73 |
ENST00000355648.8
|
PHACTR3
|
phosphatase and actin regulator 3 |
chr5_-_138338325 | 0.73 |
ENST00000510119.1
ENST00000513970.5 |
CDC25C
|
cell division cycle 25C |
chr11_+_62419025 | 0.73 |
ENST00000278282.3
|
SCGB1A1
|
secretoglobin family 1A member 1 |
chr17_+_67377272 | 0.73 |
ENST00000581322.6
ENST00000299954.13 |
PITPNC1
|
phosphatidylinositol transfer protein cytoplasmic 1 |
chr11_-_102780620 | 0.72 |
ENST00000279441.9
ENST00000539681.1 |
MMP10
|
matrix metallopeptidase 10 |
chr2_-_162242998 | 0.71 |
ENST00000627638.2
ENST00000447386.5 |
FAP
|
fibroblast activation protein alpha |
chr18_+_58862904 | 0.71 |
ENST00000591083.5
|
ZNF532
|
zinc finger protein 532 |
chr9_-_39288138 | 0.71 |
ENST00000297668.10
|
CNTNAP3
|
contactin associated protein family member 3 |
chr4_-_158173042 | 0.71 |
ENST00000592057.1
ENST00000393807.9 |
GASK1B
|
golgi associated kinase 1B |
chr7_+_80602200 | 0.70 |
ENST00000534394.5
|
CD36
|
CD36 molecule |
chr5_-_88785493 | 0.70 |
ENST00000503554.4
|
MEF2C
|
myocyte enhancer factor 2C |
chr7_+_80602150 | 0.70 |
ENST00000309881.11
|
CD36
|
CD36 molecule |
chr11_+_117179127 | 0.70 |
ENST00000278951.11
|
SIDT2
|
SID1 transmembrane family member 2 |
chr12_-_92145838 | 0.69 |
ENST00000256015.5
|
BTG1
|
BTG anti-proliferation factor 1 |
chr2_+_73892967 | 0.69 |
ENST00000409731.7
ENST00000409918.5 ENST00000442912.5 ENST00000345517.8 ENST00000409624.1 |
ACTG2
|
actin gamma 2, smooth muscle |
chr20_+_59604527 | 0.69 |
ENST00000371015.6
|
PHACTR3
|
phosphatase and actin regulator 3 |
chr2_+_195657179 | 0.68 |
ENST00000359634.10
|
SLC39A10
|
solute carrier family 39 member 10 |
chr3_-_186109067 | 0.68 |
ENST00000306376.10
|
ETV5
|
ETS variant transcription factor 5 |
chr6_+_125219804 | 0.68 |
ENST00000524679.1
|
TPD52L1
|
TPD52 like 1 |
chr7_+_80638633 | 0.67 |
ENST00000447544.7
ENST00000482059.6 |
CD36
|
CD36 molecule |
chr1_+_24319342 | 0.67 |
ENST00000361548.9
|
GRHL3
|
grainyhead like transcription factor 3 |
chr21_+_38256984 | 0.67 |
ENST00000398938.7
|
KCNJ15
|
potassium inwardly rectifying channel subfamily J member 15 |
chr1_+_24319511 | 0.67 |
ENST00000356046.6
|
GRHL3
|
grainyhead like transcription factor 3 |
chr1_+_116111395 | 0.67 |
ENST00000684484.1
ENST00000369500.4 |
MAB21L3
|
mab-21 like 3 |
chr1_+_101238090 | 0.67 |
ENST00000475289.2
|
S1PR1
|
sphingosine-1-phosphate receptor 1 |
chr16_-_57797764 | 0.67 |
ENST00000465878.6
ENST00000561524.5 |
KIFC3
|
kinesin family member C3 |
chr20_+_325536 | 0.67 |
ENST00000342665.5
|
SOX12
|
SRY-box transcription factor 12 |
chr12_+_99647749 | 0.67 |
ENST00000324341.2
|
FAM71C
|
family with sequence similarity 71 member C |
chr9_-_81688354 | 0.65 |
ENST00000418319.5
|
TLE1
|
TLE family member 1, transcriptional corepressor |
chr18_+_62715526 | 0.65 |
ENST00000262719.10
|
PHLPP1
|
PH domain and leucine rich repeat protein phosphatase 1 |
chr18_+_3449620 | 0.64 |
ENST00000405385.7
|
TGIF1
|
TGFB induced factor homeobox 1 |
chr5_+_136058849 | 0.64 |
ENST00000508076.5
|
TGFBI
|
transforming growth factor beta induced |
chr6_+_32154131 | 0.63 |
ENST00000375143.6
ENST00000324816.11 ENST00000424499.1 |
PPT2
|
palmitoyl-protein thioesterase 2 |
chr19_-_49877279 | 0.63 |
ENST00000391832.7
ENST00000344175.10 |
AKT1S1
|
AKT1 substrate 1 |
chr4_-_163613505 | 0.63 |
ENST00000339875.9
|
MARCHF1
|
membrane associated ring-CH-type finger 1 |
chr1_+_84144260 | 0.63 |
ENST00000370685.7
|
PRKACB
|
protein kinase cAMP-activated catalytic subunit beta |
chr8_+_125430333 | 0.63 |
ENST00000311922.4
|
TRIB1
|
tribbles pseudokinase 1 |
chr8_-_80080816 | 0.63 |
ENST00000520527.5
ENST00000517427.5 ENST00000379097.7 ENST00000448733.3 |
TPD52
|
tumor protein D52 |
chr1_+_44746401 | 0.62 |
ENST00000372217.5
|
KIF2C
|
kinesin family member 2C |
chrX_+_108045050 | 0.61 |
ENST00000458383.1
ENST00000217957.10 |
VSIG1
|
V-set and immunoglobulin domain containing 1 |
chr2_-_207165923 | 0.61 |
ENST00000309446.11
|
KLF7
|
Kruppel like factor 7 |
chrX_+_108044967 | 0.61 |
ENST00000415430.7
|
VSIG1
|
V-set and immunoglobulin domain containing 1 |
chr6_-_127459364 | 0.61 |
ENST00000487331.2
ENST00000483725.8 |
KIAA0408
|
KIAA0408 |
chr1_-_27490045 | 0.60 |
ENST00000536657.1
|
WASF2
|
WASP family member 2 |
chr10_-_3785197 | 0.60 |
ENST00000497571.6
|
KLF6
|
Kruppel like factor 6 |
chr17_+_67377413 | 0.60 |
ENST00000580974.5
|
PITPNC1
|
phosphatidylinositol transfer protein cytoplasmic 1 |
chr7_+_112423137 | 0.60 |
ENST00000005558.8
ENST00000621379.4 |
IFRD1
|
interferon related developmental regulator 1 |
chr10_-_3785225 | 0.60 |
ENST00000542957.1
|
KLF6
|
Kruppel like factor 6 |
chr6_+_32154010 | 0.60 |
ENST00000375137.6
|
PPT2
|
palmitoyl-protein thioesterase 2 |
chr12_+_92702843 | 0.59 |
ENST00000397833.3
|
PLEKHG7
|
pleckstrin homology and RhoGEF domain containing G7 |
chr2_-_25982471 | 0.58 |
ENST00000264712.8
|
KIF3C
|
kinesin family member 3C |
chr4_+_87832917 | 0.58 |
ENST00000395102.8
ENST00000497649.6 ENST00000540395.1 ENST00000560249.5 ENST00000511670.5 ENST00000361056.3 |
MEPE
|
matrix extracellular phosphoglycoprotein |
chr2_+_142877653 | 0.58 |
ENST00000375773.6
ENST00000409512.5 ENST00000264170.9 ENST00000410015.6 |
KYNU
|
kynureninase |
chrX_-_15664798 | 0.57 |
ENST00000380342.4
|
CLTRN
|
collectrin, amino acid transport regulator |
chr11_-_11353241 | 0.57 |
ENST00000528848.3
|
CSNK2A3
|
casein kinase 2 alpha 3 |
chr2_-_133568393 | 0.57 |
ENST00000317721.10
ENST00000405974.7 ENST00000409261.6 ENST00000409213.5 |
NCKAP5
|
NCK associated protein 5 |
chr3_+_50155024 | 0.57 |
ENST00000414301.5
ENST00000450338.5 ENST00000413852.5 |
SEMA3F
|
semaphorin 3F |
chr9_-_14722725 | 0.57 |
ENST00000380911.4
|
CER1
|
cerberus 1, DAN family BMP antagonist |
chr1_-_120051714 | 0.56 |
ENST00000579475.7
|
NOTCH2
|
notch receptor 2 |
chr9_+_72577788 | 0.56 |
ENST00000645208.2
|
TMC1
|
transmembrane channel like 1 |
chr20_+_37744630 | 0.56 |
ENST00000373473.5
|
CTNNBL1
|
catenin beta like 1 |
chr18_+_63587297 | 0.54 |
ENST00000269489.9
|
SERPINB13
|
serpin family B member 13 |
chr1_+_3624978 | 0.54 |
ENST00000378344.7
ENST00000344579.5 |
TPRG1L
|
tumor protein p63 regulated 1 like |
chr2_-_55334529 | 0.54 |
ENST00000645860.1
ENST00000642563.1 ENST00000647396.1 |
CCDC88A
|
coiled-coil domain containing 88A |
chr20_+_45407207 | 0.54 |
ENST00000372712.6
|
DBNDD2
|
dysbindin domain containing 2 |
chr12_+_92702983 | 0.53 |
ENST00000344636.6
ENST00000544406.2 |
PLEKHG7
|
pleckstrin homology and RhoGEF domain containing G7 |
chr1_+_203682734 | 0.53 |
ENST00000341360.6
|
ATP2B4
|
ATPase plasma membrane Ca2+ transporting 4 |
chr7_+_134891400 | 0.53 |
ENST00000393118.6
|
CALD1
|
caldesmon 1 |
chr9_-_95507416 | 0.53 |
ENST00000429896.6
|
PTCH1
|
patched 1 |
chrX_-_41589970 | 0.53 |
ENST00000378179.9
|
CASK
|
calcium/calmodulin dependent serine protein kinase |
chr11_+_66258467 | 0.53 |
ENST00000394066.6
|
KLC2
|
kinesin light chain 2 |
chr8_+_127735597 | 0.53 |
ENST00000651626.1
|
MYC
|
MYC proto-oncogene, bHLH transcription factor |
chr13_-_48413105 | 0.53 |
ENST00000620633.5
|
LPAR6
|
lysophosphatidic acid receptor 6 |
chr8_-_28386073 | 0.53 |
ENST00000523095.5
ENST00000522795.1 |
ZNF395
|
zinc finger protein 395 |
chr18_+_63587336 | 0.52 |
ENST00000344731.10
|
SERPINB13
|
serpin family B member 13 |
chr9_-_125484490 | 0.52 |
ENST00000444226.1
|
MAPKAP1
|
MAPK associated protein 1 |
chr20_+_45406560 | 0.52 |
ENST00000372717.5
ENST00000360981.8 |
DBNDD2
|
dysbindin domain containing 2 |
chr1_-_6360677 | 0.52 |
ENST00000377845.7
|
ACOT7
|
acyl-CoA thioesterase 7 |
chr14_+_32329341 | 0.52 |
ENST00000557354.5
ENST00000557102.1 ENST00000557272.1 |
AKAP6
|
A-kinase anchoring protein 6 |
chr6_+_20403679 | 0.51 |
ENST00000535432.2
|
E2F3
|
E2F transcription factor 3 |
chr12_-_52192007 | 0.51 |
ENST00000394815.3
|
KRT80
|
keratin 80 |
chr8_+_31639291 | 0.51 |
ENST00000651149.1
ENST00000650866.1 |
NRG1
|
neuregulin 1 |
chr14_-_73027077 | 0.51 |
ENST00000553891.5
ENST00000556143.6 |
ZFYVE1
|
zinc finger FYVE-type containing 1 |
chr7_+_134745460 | 0.51 |
ENST00000436461.6
|
CALD1
|
caldesmon 1 |
chr17_-_41065879 | 0.51 |
ENST00000394015.3
|
KRTAP2-4
|
keratin associated protein 2-4 |
chr6_+_83853576 | 0.51 |
ENST00000369687.2
|
RIPPLY2
|
ripply transcriptional repressor 2 |
chr11_+_121102666 | 0.51 |
ENST00000264037.2
|
TECTA
|
tectorin alpha |
chr7_-_112939773 | 0.50 |
ENST00000297145.9
|
BMT2
|
base methyltransferase of 25S rRNA 2 homolog |
chr12_+_96194501 | 0.50 |
ENST00000552142.5
|
ELK3
|
ETS transcription factor ELK3 |
chr18_+_58149314 | 0.50 |
ENST00000435432.6
ENST00000357895.9 ENST00000586263.5 |
NEDD4L
|
NEDD4 like E3 ubiquitin protein ligase |
chr2_+_28395511 | 0.50 |
ENST00000436647.1
|
FOSL2
|
FOS like 2, AP-1 transcription factor subunit |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 5.8 | GO:0097338 | response to clozapine(GO:0097338) |
0.7 | 3.7 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.6 | 1.7 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.6 | 5.1 | GO:0070543 | response to linoleic acid(GO:0070543) blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
0.5 | 3.8 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.4 | 4.3 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.4 | 1.5 | GO:0097325 | melanocyte proliferation(GO:0097325) |
0.4 | 1.1 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.4 | 3.6 | GO:0060005 | vestibular reflex(GO:0060005) |
0.4 | 1.4 | GO:0070982 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
0.3 | 1.4 | GO:0090095 | regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
0.3 | 1.7 | GO:0010193 | response to ozone(GO:0010193) |
0.3 | 2.0 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.3 | 2.2 | GO:0030421 | defecation(GO:0030421) |
0.3 | 2.5 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.3 | 3.6 | GO:0038129 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) ERBB3 signaling pathway(GO:0038129) |
0.3 | 0.8 | GO:0042938 | dipeptide transport(GO:0042938) |
0.3 | 0.8 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.3 | 0.8 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
0.3 | 2.0 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.2 | 0.7 | GO:0014740 | negative regulation of muscle hyperplasia(GO:0014740) |
0.2 | 1.1 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.2 | 4.5 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.2 | 0.7 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
0.2 | 0.7 | GO:0035565 | regulation of pronephros size(GO:0035565) |
0.2 | 2.4 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 1.7 | GO:0002254 | kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
0.2 | 0.6 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
0.2 | 1.8 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.2 | 0.6 | GO:0007518 | myoblast fate determination(GO:0007518) |
0.2 | 0.8 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.2 | 1.5 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.2 | 2.7 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.2 | 1.1 | GO:0006696 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
0.2 | 1.2 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.2 | 0.5 | GO:1903674 | regulation of cap-dependent translational initiation(GO:1903674) positive regulation of cap-dependent translational initiation(GO:1903676) |
0.2 | 0.8 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.2 | 0.5 | GO:0072183 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of nephron tubule epithelial cell differentiation(GO:0072183) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) negative regulation of epithelial cell differentiation involved in kidney development(GO:2000697) |
0.1 | 1.2 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.4 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.1 | 3.4 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.1 | 0.4 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.1 | 0.6 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 1.5 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.1 | 0.8 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.1 | 0.7 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.1 | 0.4 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.1 | 0.4 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
0.1 | 0.1 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.1 | 0.4 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
0.1 | 0.8 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.1 | 0.5 | GO:0036114 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.1 | 0.9 | GO:0097350 | neutrophil clearance(GO:0097350) |
0.1 | 0.9 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 1.0 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.6 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
0.1 | 0.7 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.1 | 0.6 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.1 | 0.6 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 0.3 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.1 | 0.3 | GO:0072233 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
0.1 | 1.2 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.5 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.1 | 0.3 | GO:1990654 | regulation of extrathymic T cell differentiation(GO:0033082) sebum secreting cell proliferation(GO:1990654) |
0.1 | 0.6 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.1 | 1.1 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.1 | 1.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.2 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
0.1 | 1.2 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.6 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.1 | 1.7 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 0.3 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
0.1 | 0.6 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.1 | 0.8 | GO:0044211 | CTP salvage(GO:0044211) |
0.1 | 1.9 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.1 | 0.7 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) germline stem cell asymmetric division(GO:0098728) |
0.1 | 3.1 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.1 | 0.8 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 0.3 | GO:0052331 | cytolysis by symbiont of host cells(GO:0001897) hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.1 | 0.5 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.1 | 0.4 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.1 | 1.5 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.1 | 1.1 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.1 | 0.3 | GO:0009085 | lysine biosynthetic process(GO:0009085) lysine biosynthetic process via aminoadipic acid(GO:0019878) |
0.1 | 0.7 | GO:0003138 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
0.1 | 0.5 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.1 | 0.3 | GO:0046110 | xanthine metabolic process(GO:0046110) |
0.1 | 0.8 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
0.1 | 0.3 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.1 | 1.1 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.4 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 0.6 | GO:0035290 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
0.1 | 0.3 | GO:0010157 | response to chlorate(GO:0010157) |
0.1 | 1.3 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
0.1 | 0.2 | GO:0060903 | germ-line stem cell population maintenance(GO:0030718) positive regulation of meiosis I(GO:0060903) |
0.1 | 0.3 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.1 | 0.4 | GO:0030070 | insulin processing(GO:0030070) |
0.1 | 1.0 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.4 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.1 | 0.5 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 0.3 | GO:2000638 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
0.1 | 0.7 | GO:0002911 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.1 | 0.4 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.1 | 0.2 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
0.1 | 0.2 | GO:1902523 | positive regulation of protein K63-linked ubiquitination(GO:1902523) |
0.1 | 0.6 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.1 | 0.7 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 0.7 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.1 | 1.1 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.4 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.1 | 0.3 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.1 | 0.3 | GO:0072092 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.1 | 0.3 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.1 | 0.5 | GO:0043697 | forebrain anterior/posterior pattern specification(GO:0021797) dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
0.1 | 1.7 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.5 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.1 | 0.8 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.2 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
0.1 | 0.1 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.1 | 0.2 | GO:0071486 | cellular response to light intensity(GO:0071484) cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) retinal cell apoptotic process(GO:1990009) |
0.1 | 0.5 | GO:0009597 | detection of virus(GO:0009597) |
0.1 | 0.2 | GO:0070352 | positive regulation of white fat cell proliferation(GO:0070352) |
0.1 | 0.5 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.1 | 0.4 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.1 | 0.3 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
0.1 | 0.2 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 0.9 | GO:1902548 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.1 | 0.2 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.1 | 1.0 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.2 | GO:1904845 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
0.1 | 0.4 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.1 | 0.2 | GO:2000213 | nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of urea metabolic process(GO:0034255) histone H3-R17 methylation(GO:0034971) intracellular bile acid receptor signaling pathway(GO:0038185) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
0.1 | 0.9 | GO:0035878 | nail development(GO:0035878) |
0.1 | 1.4 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.4 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 1.2 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 1.9 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 0.3 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.1 | 0.5 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.1 | 0.2 | GO:0036245 | cellular response to menadione(GO:0036245) |
0.1 | 1.4 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.1 | 0.3 | GO:0046398 | UDP-glucuronate biosynthetic process(GO:0006065) UDP-glucuronate metabolic process(GO:0046398) |
0.1 | 1.1 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.1 | 0.3 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.0 | 0.7 | GO:0038042 | dimeric G-protein coupled receptor signaling pathway(GO:0038042) |
0.0 | 0.1 | GO:1904693 | midbrain morphogenesis(GO:1904693) |
0.0 | 0.2 | GO:0050883 | negative regulation of sodium:proton antiporter activity(GO:0032416) musculoskeletal movement, spinal reflex action(GO:0050883) |
0.0 | 0.3 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.0 | 0.1 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.0 | 0.7 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.9 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.0 | 0.1 | GO:0052250 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.0 | 0.1 | GO:0014901 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.0 | 0.1 | GO:0003383 | apical constriction(GO:0003383) |
0.0 | 0.6 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.0 | 0.2 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
0.0 | 0.1 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.0 | 0.9 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 0.5 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 1.1 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.2 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.0 | 0.5 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.0 | 0.3 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.0 | 1.1 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.0 | 0.1 | GO:0061325 | pulmonary myocardium development(GO:0003350) subthalamic nucleus development(GO:0021763) deltoid tuberosity development(GO:0035993) prolactin secreting cell differentiation(GO:0060127) left lung morphogenesis(GO:0060460) pulmonary vein morphogenesis(GO:0060577) superior vena cava morphogenesis(GO:0060578) cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
0.0 | 0.3 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.0 | 0.2 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
0.0 | 0.3 | GO:0048840 | otolith development(GO:0048840) |
0.0 | 0.3 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.1 | GO:0061316 | neural crest cell fate commitment(GO:0014034) canonical Wnt signaling pathway involved in heart development(GO:0061316) canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:0061317) |
0.0 | 0.3 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.0 | 0.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.2 | GO:2000852 | regulation of corticosterone secretion(GO:2000852) |
0.0 | 0.2 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.0 | 0.9 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.0 | 0.5 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.0 | 0.3 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.0 | 0.2 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
0.0 | 0.6 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 1.0 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 0.1 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.0 | 0.5 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.0 | 0.3 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.0 | 1.1 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.0 | 0.8 | GO:0097320 | membrane tubulation(GO:0097320) |
0.0 | 0.9 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.0 | 0.7 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.4 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.0 | 0.2 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.0 | 0.6 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.0 | 0.2 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.0 | 0.3 | GO:0021759 | globus pallidus development(GO:0021759) |
0.0 | 0.4 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.0 | 0.7 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.0 | 0.1 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.0 | 0.2 | GO:1900223 | positive regulation of beta-amyloid clearance(GO:1900223) |
0.0 | 0.6 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.0 | 0.2 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.0 | 0.5 | GO:0043584 | nose development(GO:0043584) |
0.0 | 0.2 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.0 | 0.3 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.0 | 0.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.2 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.0 | 0.1 | GO:0031550 | positive regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031550) |
0.0 | 0.7 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 1.9 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.3 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 | 0.2 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.0 | 0.1 | GO:0042109 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.0 | 0.3 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.0 | 0.2 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.0 | 0.3 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.0 | 0.1 | GO:1903770 | regulation of telomere maintenance via recombination(GO:0032207) negative regulation of telomere maintenance via recombination(GO:0032208) negative regulation of single strand break repair(GO:1903517) negative regulation of beta-galactosidase activity(GO:1903770) telomere single strand break repair(GO:1903823) negative regulation of telomere single strand break repair(GO:1903824) |
0.0 | 0.7 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.0 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.0 | 0.3 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
0.0 | 0.1 | GO:1903756 | positive regulation of dendritic spine maintenance(GO:1902952) regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.0 | 0.2 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) protein desumoylation(GO:0016926) |
0.0 | 0.4 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.0 | 0.1 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.0 | 0.2 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.0 | 0.1 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.0 | 0.3 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.0 | 0.1 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
0.0 | 0.1 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) regulation of cardiac vascular smooth muscle cell differentiation(GO:2000722) positive regulation of cardiac vascular smooth muscle cell differentiation(GO:2000724) |
0.0 | 0.1 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.0 | 0.2 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.4 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.0 | 0.8 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
0.0 | 0.1 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.0 | 0.8 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.0 | 0.7 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.0 | 0.8 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.0 | 0.1 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.0 | 0.1 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.0 | 0.2 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.0 | 0.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.0 | 2.4 | GO:0030183 | B cell differentiation(GO:0030183) |
0.0 | 0.3 | GO:0043217 | myelin maintenance(GO:0043217) |
0.0 | 0.2 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
0.0 | 0.4 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.0 | 0.2 | GO:0000101 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.0 | 1.8 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.5 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.0 | 0.1 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.0 | 0.1 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.0 | 0.3 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.0 | 0.1 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.0 | 0.1 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.0 | 0.2 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.0 | 0.2 | GO:0060992 | response to fungicide(GO:0060992) |
0.0 | 0.4 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.1 | GO:0061430 | bone trabecula formation(GO:0060346) bone trabecula morphogenesis(GO:0061430) |
0.0 | 2.0 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.2 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.0 | 0.1 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.0 | 0.1 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.0 | 0.3 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.0 | 0.0 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.0 | 0.3 | GO:0060143 | positive regulation of syncytium formation by plasma membrane fusion(GO:0060143) positive regulation of myoblast fusion(GO:1901741) |
0.0 | 0.3 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.0 | 0.1 | GO:0014062 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) regulation of serotonin secretion(GO:0014062) |
0.0 | 1.3 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.1 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.0 | 0.2 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.1 | GO:0038016 | insulin receptor internalization(GO:0038016) |
0.0 | 0.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.4 | GO:0031167 | rRNA methylation(GO:0031167) |
0.0 | 0.1 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.0 | 0.1 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.0 | 0.2 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.0 | 0.2 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.0 | 0.1 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.0 | 0.0 | GO:0031247 | actin rod assembly(GO:0031247) |
0.0 | 0.3 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.0 | 0.2 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.0 | 0.1 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
0.0 | 0.0 | GO:0002304 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
0.0 | 0.1 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.0 | 0.0 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
0.0 | 0.3 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.1 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.1 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.0 | 0.3 | GO:0033189 | response to vitamin A(GO:0033189) |
0.0 | 0.2 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.1 | GO:0032909 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.0 | 0.2 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.0 | 0.1 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.0 | 0.0 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
0.0 | 0.3 | GO:0048665 | neuron fate specification(GO:0048665) |
0.0 | 0.4 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.0 | 0.1 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.0 | 0.2 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.1 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.0 | 0.4 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.0 | 0.1 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
0.0 | 0.3 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.1 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.0 | 0.1 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.0 | 0.1 | GO:0036371 | T-tubule organization(GO:0033292) protein localization to T-tubule(GO:0036371) |
0.0 | 0.1 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.0 | 0.2 | GO:0000338 | protein deneddylation(GO:0000338) |
0.0 | 1.2 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
0.0 | 0.3 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 0.2 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 4.5 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.6 | 1.7 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.4 | 6.2 | GO:0030478 | actin cap(GO:0030478) |
0.4 | 1.2 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.3 | 1.6 | GO:0035838 | growing cell tip(GO:0035838) |
0.3 | 5.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.3 | 0.8 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.3 | 1.8 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.3 | 1.0 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.2 | 9.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.2 | 3.9 | GO:0032426 | stereocilium tip(GO:0032426) |
0.2 | 0.5 | GO:0016938 | kinesin I complex(GO:0016938) |
0.1 | 0.3 | GO:1902737 | dendritic filopodium(GO:1902737) |
0.1 | 1.2 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 0.5 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.1 | 0.4 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
0.1 | 1.4 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.4 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.1 | 0.4 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.1 | 0.2 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 0.4 | GO:0005712 | chiasma(GO:0005712) |
0.1 | 0.2 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
0.1 | 0.2 | GO:0097444 | spine apparatus(GO:0097444) |
0.1 | 3.8 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 0.9 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 1.1 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.9 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.2 | GO:0005600 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
0.1 | 0.6 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 0.7 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 0.4 | GO:0035976 | AP1 complex(GO:0035976) |
0.1 | 0.6 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.8 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.9 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 0.8 | GO:0033643 | host cell part(GO:0033643) |
0.0 | 0.7 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.8 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.0 | 0.2 | GO:0036398 | TCR signalosome(GO:0036398) |
0.0 | 0.9 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.1 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
0.0 | 0.3 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.0 | 0.2 | GO:0097651 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.0 | 0.3 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.0 | 0.9 | GO:0005652 | nuclear lamina(GO:0005652) |
0.0 | 0.3 | GO:0032584 | growth cone membrane(GO:0032584) |
0.0 | 0.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 1.1 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.3 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.0 | 0.2 | GO:0014802 | terminal cisterna(GO:0014802) |
0.0 | 0.2 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.0 | 0.5 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.4 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.0 | 1.5 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.4 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.0 | 0.2 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.0 | 0.3 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.6 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.0 | 0.3 | GO:0070449 | elongin complex(GO:0070449) |
0.0 | 0.3 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.0 | 0.2 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.0 | 0.5 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.7 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 0.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.4 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.3 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.0 | 0.3 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.0 | 0.6 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 2.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.1 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.0 | 1.7 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.3 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 0.2 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 0.7 | GO:0097228 | sperm principal piece(GO:0097228) |
0.0 | 0.5 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 0.3 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.0 | 2.0 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.2 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.0 | 1.1 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.3 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 1.0 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.3 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 1.5 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.3 | GO:0071437 | invadopodium(GO:0071437) |
0.0 | 2.0 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.9 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.1 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 0.2 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 1.6 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.1 | GO:0043203 | axon hillock(GO:0043203) |
0.0 | 0.1 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.0 | 0.4 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.1 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.3 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.1 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.0 | 0.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.0 | 0.3 | GO:0002102 | podosome(GO:0002102) |
0.0 | 8.5 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 1.3 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.3 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 1.1 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.0 | 0.2 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 1.5 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 1.3 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.8 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.3 | GO:0005685 | U1 snRNP(GO:0005685) |
0.0 | 0.1 | GO:0005688 | U6 snRNP(GO:0005688) |
0.0 | 0.5 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.5 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.7 | 2.0 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
0.6 | 5.1 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
0.5 | 1.6 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.5 | 1.6 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.4 | 1.7 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.4 | 2.4 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.4 | 4.3 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.3 | 5.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.3 | 6.9 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.3 | 0.9 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.3 | 1.2 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.3 | 1.4 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
0.3 | 3.9 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.3 | 3.8 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.2 | 0.9 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 1.8 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.2 | 2.0 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
0.2 | 0.6 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
0.2 | 6.1 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 1.0 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.2 | 1.2 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 1.1 | GO:0004310 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
0.2 | 0.5 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
0.2 | 1.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.2 | 1.0 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.2 | 1.1 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.2 | 1.7 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.2 | 0.8 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.1 | 0.7 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.8 | GO:0042835 | BRE binding(GO:0042835) |
0.1 | 1.0 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 0.7 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.1 | 0.7 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.1 | 0.6 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.6 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.1 | 0.6 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.7 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.1 | 1.2 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.9 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 3.1 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.5 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.1 | 0.9 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.1 | 0.3 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 2.9 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.8 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 0.3 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 0.6 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.3 | GO:0004577 | N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity(GO:0004577) |
0.1 | 0.3 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.1 | 0.3 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.1 | 1.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.4 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 0.3 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.3 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 0.5 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 0.6 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.1 | 0.8 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 1.0 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.1 | 1.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.9 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.1 | 0.2 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 2.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.2 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
0.1 | 1.0 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 0.4 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.8 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 0.4 | GO:0016316 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.1 | 0.3 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.1 | 0.6 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.3 | GO:0097108 | smoothened binding(GO:0005119) hedgehog family protein binding(GO:0097108) |
0.1 | 3.2 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.2 | GO:0004651 | polynucleotide 5'-phosphatase activity(GO:0004651) |
0.1 | 0.6 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.7 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.5 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 0.3 | GO:0016807 | cysteine-type carboxypeptidase activity(GO:0016807) cysteine-type exopeptidase activity(GO:0070004) |
0.1 | 1.1 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 0.7 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.2 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
0.1 | 0.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 1.2 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.2 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.1 | 0.9 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 0.8 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.0 | 0.2 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.0 | 0.4 | GO:0016433 | rRNA (adenine) methyltransferase activity(GO:0016433) |
0.0 | 0.3 | GO:0034046 | poly(G) binding(GO:0034046) |
0.0 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 0.2 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.0 | 0.6 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 1.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.7 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.2 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
0.0 | 0.4 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.0 | 0.3 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.0 | 0.7 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.5 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 1.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.4 | GO:0042731 | PH domain binding(GO:0042731) |
0.0 | 0.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.9 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 1.2 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.5 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.9 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.0 | 0.1 | GO:0055100 | adiponectin binding(GO:0055100) |
0.0 | 0.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.7 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.2 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.0 | 0.8 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 0.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.0 | 0.1 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) ethanolaminephosphotransferase activity(GO:0004307) |
0.0 | 5.1 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.1 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.0 | 0.2 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 0.1 | GO:0050692 | DBD domain binding(GO:0050692) |
0.0 | 0.5 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 1.2 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.5 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.0 | 0.7 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.0 | 1.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 3.9 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.3 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.0 | 0.1 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
0.0 | 0.1 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.0 | 1.2 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.1 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.0 | 0.2 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.0 | 0.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.6 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.3 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.0 | 0.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.4 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.2 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.0 | 0.7 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.7 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 1.8 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.3 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.0 | 0.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.4 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.0 | 0.4 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.1 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
0.0 | 0.3 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 0.1 | GO:0003983 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
0.0 | 0.5 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.6 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 2.2 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 0.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.0 | 0.2 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 0.3 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.4 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.0 | 0.3 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.4 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.0 | 0.4 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.3 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.0 | 1.1 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.0 | 0.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.1 | GO:0031208 | POZ domain binding(GO:0031208) |
0.0 | 0.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 1.8 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.0 | 0.1 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.0 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.0 | 0.4 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.7 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.4 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.2 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.0 | 0.4 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 1.9 | GO:0035326 | enhancer binding(GO:0035326) |
0.0 | 1.2 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.4 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.8 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.2 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.0 | 1.2 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.1 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
0.0 | 0.4 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.0 | 1.6 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 0.1 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.9 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 2.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.0 | 0.3 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.2 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 0.2 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.0 | 1.7 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.5 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.6 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.0 | 0.1 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.0 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.2 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.3 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 6.3 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 3.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 7.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 4.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 5.2 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 2.6 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 0.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 1.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 2.9 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 3.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 1.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 0.7 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 2.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 2.8 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 1.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 1.0 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.5 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 2.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.3 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 1.9 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 1.8 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 1.0 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 1.9 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.3 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.8 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.8 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.7 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 0.8 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 1.3 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.7 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 0.4 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 1.2 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.9 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 1.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 1.4 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.3 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 4.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 1.0 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.7 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.5 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.7 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.3 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.5 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.2 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 7.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 2.1 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 2.5 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 4.3 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 6.9 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 3.8 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 0.7 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 1.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 1.5 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 3.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 1.7 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 1.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 1.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 1.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 1.0 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 1.5 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 0.7 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 0.9 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 5.0 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 3.0 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 6.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 1.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.9 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 1.8 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 1.8 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 1.8 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.7 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 1.9 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.5 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.5 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.7 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 1.0 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.0 | 0.9 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.9 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 1.4 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 1.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 5.2 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 1.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.6 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 3.6 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.7 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 1.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.2 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.0 | 1.1 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 2.1 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 1.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.9 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 2.2 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.6 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.0 | 0.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.4 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.0 | 0.8 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.7 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.3 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.5 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.0 | 0.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.6 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 2.6 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.4 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.6 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.0 | 0.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.1 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.6 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |